News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
NASDAQ Golden Dragon CN Index Up 6.4%; Alibaba (BABA.US) Jumps Up 8%+
The Chinese government work report propounded an economic growth target of around 5% for this year. Correspondingly, the NASDAQ Golden Dragon China Index surged 485 points, or 6.4%...
Reset
Send
The window will close in 5 seconds
NASDAQ Golden Dragon CN Index Up 6.4%; Alibaba (BABA.US) Jumps Up 8%+
Close
Recommend
123
Positive
160
Negative
97
 
 

The Chinese government work report propounded an economic growth target of around 5% for this year. Correspondingly, the NASDAQ Golden Dragon China Index surged 485 points, or 6.4%, to 8,073.

Chinese ADRs mushroomed, with Alibaba (BABA.US)      up 8.6%; Baidu (BIDU.US)      , Bilibili (BILI.US)      , Vipshop (VIPS.US)      , and Pinduoduo (PDD.US)      climbing between 5.4% and 6%. New Oriental Education (EDU.US)      , Kingsoft Cloud (KS.US), and Trip.com (TCOM.US)      soared 6.4%, 7.4%, and 7.8%, respectively, while GDS (GDS.US)      swelled 10.2%. Tencent (TCEHY.US)      rallied 6.5%.

Related NewsG Sachs Drops BYD COMPANY's TP to $428, Predicts Intensified Competition to Drag 2Q25 GPM Down by 3 ppts
In the auto sector, XPeng (XPEV.US)      leaped 7.1%, Geely's Zeekr (ZK.US)      jumped up 10.2%, Nio (NIO.US)      and Li Auto (LI.US)      advanced 3.1% and 3.6%, respectively, and BYD (BYDDY.US)      swelled 2.5%.
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.